Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

MLA

de Vries, Hielke M., et al. “Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 41, no. 31, Nov. 2023, pp. 4872–80. EBSCOhost, https://doi.org/10.1200/JCO.22.02894.

APA

de Vries, H. M., Rafael, T. S., Gil-Jimenez, A., de Feijter, J. M., Bekers, E., van der Laan, E., Lopez-Yurda, M., Hooijberg, E., Broeks, A., Peters, D., Seignette, I. M., Pos, F. J., Horenblas, S., van Rhijn, B. W. G., Jordanova, E. S., Brouwer, O. R., Schaake, E., & van der Heijden, M. S. (2023). Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 41(31), 4872–4880. https://doi.org/10.1200/JCO.22.02894

Chicago

de Vries, Hielke M, Tynisha S Rafael, Alberto Gil-Jimenez, Jeantine M de Feijter, Elise Bekers, Elsbeth van der Laan, Marta Lopez-Yurda, et al. 2023. “Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 41 (31): 4872–80. doi:10.1200/JCO.22.02894.